GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) continues to trend upward in recent weeks heading back towards all-time highs of $1.20 from last year.
GWPH nearly tripled...
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) skyrocketed on Monday after the Company announced positive Phase 3 trial data for its drug Epidiolex, for the treatment...
